Skip to content
Hodoodo.comHodoodo.com

MedKoo Biosciences

Sales@hodoodo.com, Tel: +1 919-636-5577; Fax: +1 919-980-4831

  • Menu
  • Login / Register
    • No products in the cart.

  • Structure Search
  • Cart

    No products in the cart.

  • Home
  • Products
  • Drug Synthesis
  • Ordering
    • How to Order
    • Terms & Conditions
    • Privacy Policy
  • Services
    • Custom Synthesis
    • Technical Support
  • About Us
  • Contact Us
  • Resources
    • Hodoodo chemical nomenclature
    • Organic chemistry acronyms
    • Chemistry abbreviations and acronyms
    • NMR peaks of solvent residue

Ambrisentan

CAT# 326690
CAS# 177036-94-1
Ambrisentan, also known as BSF-208075 and LU-208075, is a drug indicated for use in the treatment of pulmonary hypertension. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor (ETA). Ambrisentan significantly improved exercise capacity (6-minute walk distance) compared with placebo in two double-blind, multicenter trials (ARIES-1 and ARIES-2). Ambrisentan was approved by the U.S. Food and Drug Administration (FDA) and European Medicines Agency, and designated an orphan drug, for the treatment of pulmonary hypertension.
Synthetic Routes

Ambrisentan route 1

Synthetic Reference

Isolation, identification, characterization, synthesis and quality control strategy of new process-related impurities in ambrisentan; Feng, Wei-Dong; Zhuo, Song-Ming; Zhang, Fu-Li Journal of Pharmaceutical and Biomedical Analysis Volume 165 Pages 325-337 Journal; 2019

Ambrisentan route 2

Synthetic Reference

Multistep process for preparation of ambrisentan and darusentan; Satyanarayana Reddy, Manne; Nagaraju, Chakilam; Ramprasad, Achampeta Kodanda; Assignee MSN Laboratories Limited, India 2010; Patent Information; Jun 24, 2010; WO 2010070658 A2

Ambrisentan route 3

Synthetic Reference

Study on the synthesis of ambrisentan; Li, Xiao-gang; Yingyong Huagong; Volume 43; Issue 9; Pages 1675-1678; Journal; 2014

Ambrisentan route 4

Synthetic Reference

Process for preparation of Ambrisentan and intermediates thereof; Lin, Feng; Zhu, Xiaofeng; Chen, Jianli; Xu, Qiulong; Assignee Shanghai Institute of Pharmaceutical Industry, Peop. Rep. China; 2013; Patent Information; Nov 21, 2013; WO 2013170778 A1

Ambrisentan route 5

Synthetic Reference

Method for preparation of (S)-2-hydroxy-3-methoxy-3,3-diphenylpropanoic acid and ambrisentan via optical resolution of its racemate using commercially available (S)-(+)-1,2,3,4-tetrahydro-1-naphthylamine; Amagasa, Katsuaki; Oonami, Toshihiko; Assignee Toa Eiyo, Ltd., Japan, 2017; Patent Information; Jul 27, 2017; JP 2017128528 A

Ambrisentan route 6

Synthetic Reference

LC-MS/MS characterization of forced degradation products of ambrisentan: development and validation of a stability-indicating RP-HPLC method; Ramisetti, Nageswara Rao; Kuntamukkala, Ramakrishna; New Journal of Chemistry; Volume 38; Issue 7; Pages 3050-3061; Journal; 2014
Support
  • Tel: +1 919-636-5577
  • Fax: +1 919-980-4831
  • Email: Sales@hodoodo.com

Products
  • Latest Products
  • Featured Product
  • Products Categories

Stay In Touch
MedKoo Biosciences @ 2021 All Rights Reserved. 网站设计VcuSoft
  • Home
  • Products
  • Drug Synthesis
  • Ordering
    • How to Order
    • Terms & Conditions
    • Privacy Policy
  • Services
    • Custom Synthesis
    • Technical Support
  • About Us
  • Contact Us
  • Resources
    • Hodoodo chemical nomenclature
    • Organic chemistry acronyms
    • Chemistry abbreviations and acronyms
    • NMR peaks of solvent residue
  • Newsletter
  • [wcas-search-form]

Login

Lost your password?

Register

Your personal data will be used to support your experience throughout this website, to manage access to your account, and for other purposes described in our privacy policy.